D-Arabinose [10323-20-3]
Katalog-Nummer NB-64-18906-1mL
Size : 1mLx10mM(inDMSO)
Contact local distributor :
Telefonnummer : +1 850 650 7790
Remove All
D-Arabinose
Copy Product InfoSynonyms:
Catalog No. T2S0461 Copy Product Info
Purity: 99.91%
Inexpensive starting material for chiral synthesis.
Cas No. 10323-20-3
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:99.91%
Appearance:Solid
Color:White
Contact us for more batch information
Product Information
D-Arabinose AI Summary
D-Arabinose demonstrates versatile bioactivity across various biological systems. It inhibits Human acrosin, showing 50.0% inhibition with aldopentoses and 36.0% inhibition with aldoses. In rat L6 cells, it increases [3H]2-deoxy-D-glucose uptake by a fold change (FC) of 1.38 when preincubated with 20 mM D-glucose for 24 hours, indicating potential bioactivity in glucose uptake. For Neisseria meningitidis lgtC, D-Arabinose shows an enzyme efficiency with a Kcat/Km ratio of 0.1 /mM/min. Additionally, it inhibits the Menin-MLL interaction in MLL-related leukemias with a potency of 31622.8 nM and also targets GCN5L2 with a potency of 2238.7 nM. In Caenorhabditis elegans N2 L1 larvae, it reduces body size at concentrations of 16 mM and 42 mM, with activity percentages of 15.2% and 7.8% respectively. At 42 mM, it exhibits an IC50 value of 7500000.0 nM under monoxenic conditions, highlighting its potential in inhibiting larval growth..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Inexpensive starting material for chiral synthesis. |
| Molecular Weight | 150.13 |
| Formula | C5H10O5 |
| Cas No. | 10323-20-3 |
| Smiles | [C@@H]([C@@H](CO)O)([C@@H](C=O)O)O |
| Relative Density. | 1.757g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 30 mg/mL (199.83 mM), Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (13.32 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||